Navigation Links
Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half '09
Date:5/14/2009

    New manufacturing facility opens with substantially increased capacity
    for continued growth

TORONTO, May 14 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (TSX:MBX) announced today robust double digit growth in sales, improved cash flow, and reduced operating losses for the second quarter ended March 31, 2009.

In a news release today, William J. Gastle, CEO of Microbix said "Our 43% growth in the first half of 2009 coupled with the strong growth over the past three years indicates the potential for our base business. The new manufacturing facility is now fully operational, cash flow is increasing and the shareholder value creation opportunity is still available in all three pipeline products albeit somewhat delayed."

First Quarter Highlights

Core Business

In the second quarter, sales improved over 30% per cent compared to the same quarter last year. "We exceeded our sales target again in the second quarter," Mr. Gastle continued "and we are on a path to meet or exceed projections for this fiscal year. Subsequent to the second quarter, the new core business manufacturing facility opened with significantly improved capacity. Microbix fortunately operates in a major market with an ongoing strong demand for virology products."

Influenza Vaccine Business

The Hunan China manufacturing joint venture continues making progress as internal milestones are met by both partners. Microbix and Hunan are completing the pre-conditions that have been set for financing. Both levels of government in China are involved in the project. Recent events resulting from the emergence of the H1N1 virus strain that spread globally in April has increased the level of urgency of this project in China. The Feasibility Study has determined the capital required for this project. The Hunan Liuyang Biomedical Park under the supervision of Microbix financed the Study.
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
4. Microbix Announces A New Technology Platform For The SST Project
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
7. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
8. Kline Study: Better Brushing Habits Boost European Oral Care Sales
9. BioElectronics Corporation Announces Singapore and Malaysia Sales
10. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
11. AMDLs Jade Pharmaceutical Subsidiary Announces New Product Strategy; Six New Products, Including One With Sales Projected at Upwards of $10 Million, Under Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a ... of autologous cell therapies, announced today the publication of ... conjunction with co-authors from Kyoto University and the University ... clinical research using dermal sheath cup (DSC) cells to ... paper entitled " Hair Follicle Dermal Stem Cells Regenerate ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 ... peer-reviewed publication of original research, reviews and editorials ... and clinical practice, today published a provocative article ... the development, progression and potential treatment of prostate ... endocrinology research and proposes the possibility that there ...
(Date:12/19/2014)... December 19, 2014 Charm Sciences is ... for the Detection of Aflatoxin M1 in raw commingled ... independent third party validation. The peer reviewed report of ... the Institute for Agricultural and Fisheries Research (ILVO-T&V) has ... , Aflatoxin B1, the most toxic aflatoxin and a ...
(Date:12/19/2014)... 19, 2014 Bina Technologies, Inc. (Bina, ... they have been acquired by Roche (SIX: RO, ROG; ... held company that provides a big data platform for ... data for the academic and translational research markets.  Bina ... will continue to focus on development of their innovative ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today reported the ... August 31, 2008. All dollar amounts referenced,herein are in ... 2008, our cash and cash equivalents totaled $9.8 million,compared ... net loss for the third quarter of 2008 was ...
... 15 Quincy Bioscience (Madison, WI),announces that ... of the jellyfish protein apoaequorin, has displayed ... subjects tested. The Prevagen,Memory Study included 56 ... mg/day). The findings suggest that supplementation with,apoaequorin, ...
... 08/07 ... millions sales change millions sales change, ... 16 Other EU countries (2) 7.1 24 17 8.6 ... 24 1.8 5 18, SLIT ...
Cached Biology Technology:Vasogen Announces Third Quarter 2008 Results 2Vasogen Announces Third Quarter 2008 Results 3Vasogen Announces Third Quarter 2008 Results 4Vasogen Announces Third Quarter 2008 Results 5Vasogen Announces Third Quarter 2008 Results 6Vasogen Announces Third Quarter 2008 Results 7Vasogen Announces Third Quarter 2008 Results 8Vasogen Announces Third Quarter 2008 Results 9Vasogen Announces Third Quarter 2008 Results 10Jellyfish Protein Shows Potential to Help With Memory 2Jellyfish Protein Shows Potential to Help With Memory 3Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14% 2Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14% 3
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
(Date:12/3/2014)... GLENDALE, Ariz. , Dec. 2, 2014 ... biometric hand readers, Inception Technologies is pleased to announce ... it easier for customers to collect the workforce data ... the problems that have been left by existing readers. ... to user interface, connectivity and modern technology. Older models ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... in the rugged Marquesas Islands (French Polynesia) have increased the ... research and collecting in conjunction with the Vascular Flora ... Polynesie franaise projects have yielded 62 new species of ... 360, of which 18 are newly described and illustrated in ...
... available in German . They live their lives upside ... position, sloths spend most of their lives hanging in trees upside ... Very slowly. But why are sloths so ,lazy,? And how has ... in the course of evolution? Zoologists of the Friedrich Schiller University ...
... to be genes that, when mutated, change healthy cells into ... of the University of Southern California (USC) have proven that ... paving the way to a safer and more practical approach ... cell therapy. "The reality may be more complicated than ...
Cached Biology News:Marquesas Islands in French Polynesia yield 18 new species of rare ferns and flowering plants 2The decoding of slowness 2USC research: Cancer cells and stem cells share same origin 2
... Partek Genomics Solution is a comprehensive ... data visualization specifically designed to reliably ... for high-dimensional genomic studies containing thousands ... fast, memory efficient and will analyze ...
Kit contains: Bio-Rad Amplification Reagent, 2x Amplification Diluent, Streptavidin-HRP, Blocking Reagent, and Phosphate Buffered Saline....
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
Intestinal Epithelium Differentiation Environment...
Biology Products: